Clin2
NCT06990685Possibly a fitNot yet recruiting

Salidroside supplement for IVF success in women over 35

SalidrosideRandomized Controlled TrialIn Vitro FertilizationAssisted Reproductive Technology

Part of Women’s health & pregnancy clinical trials.

This study tests whether a plant-based supplement called salidroside can improve pregnancy outcomes in women aged 35–40 with a low egg supply who are undergoing IVF. It may help increase your chances of a successful pregnancy.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
370 people
Ages
35 years to 39 years
Study type
Interventional

Who can take part

  • You are between 35 and 40 years old.
  • This is your first or second IVF cycle (including ICSI or using donor sperm).
  • You have a low egg supply, shown by a previous IVF cycle producing only 1–9 eggs, or by low hormone levels (AMH or AFC).
  • You do not have a bleeding disorder, major uterine problems, or a history of three or more miscarriages.
  • You have not taken salidroside before or during the trial.
  • You are not using a specific ovarian stimulation protocol that would interfere with the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06150703Recruiting· Phase 3
Luteal phase support with GnRH agonist after egg retrieval trigger

This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.

Bondy
NCT06766604Recruiting
Super-GDF9 for egg maturation in women with PCOS

This study tests a protein called Super-GDF9 added to the lab process of maturing eggs from very small follicles. It may help women with PCOS produce more usable eggs for in vitro fertilization (IVF).

Ho Chi Minh City
NCT07121751Not yet recruiting· Phase 4
Improving egg collection for low responders in IVF treatment

This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.

Budapest
NCT07685431Recruiting
Alpha-lipoic acid for IVF in women 35-45

This trial tests whether taking alpha-lipoic acid (an antioxidant supplement) before and during IVF can improve pregnancy success in women aged 35–45 using their own eggs. It aims to see if the supplement can help counter age-related declines in egg quality.

Kaohsiung City
NCT04719000Recruiting· Phase 4
Personalized LH addition during IVF to improve egg growth

This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.

Barcelona
NCT06794047Recruiting
Vitamin C for IVF in women with low ovarian reserve

This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.

Beijing, Beijing Municipality

Hear when a new Randomized Controlled Trial trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.